Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties
| Class:Id | LiteratureReference:9818652 |
|---|---|
| _displayName | Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties |
| _timestamp | 2022-10-19 21:08:54 |
| author | [Person:9036506] Yokoyama, Akihiko [Person:6805622] Kitabayashi, Issay [Person:9818654] Ayton, Paul M [Person:5621772] Cleary, Michael L [Person:3301861] Ohki, Misao |
| created | [InstanceEdit:9818653] Orlic-Milacic, Marija, 2022-10-19 |
| journal | Blood |
| pages | 3710-8 |
| pubMedIdentifier | 12393701 |
| title | Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties |
| volume | 100 |
| year | 2002 |
| (literatureReference) | [Summation:9818595] TASP1 (Threonine aspartase 1), a threonine-type endopeptidas... [Summation:9818640] Based on experiments performed in wild-type and Tasp1 null m... [Reaction:9818574] TASP1 cleaves KMT2A [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties (9818652)
